drugset / Trial / NCT03622476

Pharmacokinetic (PK)Research on Chinese Children of Hemophilia

NCT03622476 ↗

Phase 4 Unknown 155 enrolled Beijing Children's Hospital
NaSingle-groupOpen-labelTreatment

Summary

The study start on June 30, 2018. The Severe(F Ⅷ\<1%) hemophilia A children without F Ⅷ inhibitor combining were recruited to Test the concentration of the drug in the blood to provide better treatment.

Timeline

Start
2018-06-30
Primary completion
2021-07-30
Completion
2021-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject concentrated FVIII Unknown 50 iu/kg Intravenous

Indications

No indication recorded.